Skip to main content

Research

The Department of Pathology is deeply invested in scientific efforts to improve treatments in our field. Learn more about our department’s investigations below.

Message from the Vice Chair

"We are driven by a shared passion for discovery and a deep commitment to advancing human health through innovative research programs and collaborative partnerships among scientists and pathologists."

Peng Ji, MD, PhD
Vice Chair of Research 

Read Full Message

Areas of Research

Members of the Department of Pathology are defining the cellular and molecular basis of disease toward the development of new and improved strategies to diagnose and treat, inherited, acquired and infectious disorders. Learn more about the work being done in our labs.

Research Areas

Affiliated Research Centers and Institutes

The faculty members of Northwestern University Feinberg School of Medicine’s Department of Pathology are engaged in research within the department and throughout Northwestern Medicine and Northwestern University. Our work throughout the community, including director appointments, illustrate the importance we put on scientific collaboration.

Research Cores

Core facilities provide cost-efficient access of state-of-the-art equipment, the most current technologies and expert technical advice to individual scientists.

Learn more about our affiliated cores

Access Research Resources

Recent Publications

Verticillium dahliae Elicitor VdSP8 Enhances Disease Resistance Through Increasing Lignin Biosynthesis in Cotton.

Wang Y, Qin J, Wei M, Liao X, Shang W, Chen J, Subbarao KV, Hu X.

Plant Cell Environ. 2025 Jan;48(1):728-745. doi: 10.1111/pce.15170. Epub 2024 Sep 26.

Higher sensitivity of pericardial fluid cytology than biopsy in malignant effusions with potential explanation of false-negative cytology: A multi-institutional analysis.

Takeda K, Gereg C, Liu X, Ma W, Bearse M, Tang H, Delfino I, Huang E, Lin X, Chandler JB, Wang H.

Cytopathology. 2025 Jan;36(1):31-40. doi: 10.1111/cyt.13447. Epub 2024 Sep 20.

ATEC23 Challenge: Automated prediction of treatment effectiveness in ovarian cancer using histopathological images.

Wang CW, Firdi NP, Chu TC, Faiz MFI, Iqbal MZ, Li Y, Yang B, Mallya M, Bashashati A, Li F, Wang H, Lu M, Xia Y, Chao TK.

Med Image Anal. 2025 Jan;99:103342. doi: 10.1016/j.media.2024.103342. Epub 2024 Sep 5.

AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis.

Sterling RK, Patel K, Duarte-Rojo A, Asrani SK, Alsawas M, Dranoff JA, Fiel MI, Murad MH, Leung DH, Levine D, Taddei TH, Taouli B, Rockey DC.

Hepatology. 2025 Jan 1;81(1):321-357. doi: 10.1097/HEP.0000000000000845. Epub 2024 Mar 15.

Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline.

Patel K, Asrani SK, Fiel MI, Levine D, Leung DH, Duarte-Rojo A, Dranoff JA, Nayfeh T, Hasan B, Taddei TH, Alsawaf Y, Saadi S, Majzoub AM, Manolopoulos A, Alzuabi M, Ding J, Sofiyeva N, Murad MH, Alsawas M, Rockey DC, Sterling RK.

Hepatology. 2025 Jan 1;81(1):358-379. doi: 10.1097/HEP.0000000000000842. Epub 2024 Mar 15.

Selective synergistic effects of oxalic acid and salicylic acid in enhancing amino acid levels and alleviating lead stress in Zea mays L.

Gupta M, Kumar S, Dwivedi V, Gupta DG, Ali D, Alarifi S, Patel A, Yadav VK.

Plant Signal Behav. 2024 Dec 31;19(1):2400451. doi: 10.1080/15592324.2024.2400451. Epub 2024 Sep 5.

Integrating Hydrogels and Biomedical Plastics via In Situ Physical Entanglements and Covalent Bonding.

Ma Z, Obuseh FO, Freedman BR, Kim J, Torre M, Mooney DJ.

Adv Healthc Mater. 2024 Dec 25:e2402605. doi: 10.1002/adhm.202402605. Online ahead of print.

Differentiating reactive and neoplastic gamma-delta (γδ) T-cell expansions in the peripheral blood and bone marrow.

Tariq H, Ilyas Z, Fu L, Liu Y, Chen QC, Wolniak K, Chen YH.

Cytometry B Clin Cytom. 2024 Dec 25. doi: 10.1002/cyto.b.22220. Online ahead of print.

A novel STAT3 CCD inhibitor for suppressing macrophage activation and lipopolysaccharide-induced acute lung injury.

Yang S, Zhou S, Wang W, Cao L, Xue T, Xu J, Lv K, Huang M.

Int Immunopharmacol. 2024 Dec 25;143(Pt 2):113523. doi: 10.1016/j.intimp.2024.113523. Epub 2024 Oct 29.

Heterozygous UBR5 variants result in a neurodevelopmental syndrome with developmental delay, autism, and intellectual disability.

Sabeh P, Dumas SA, Maios C, Daghar H, Korzeniowski M, Rousseau J, Lines M, Guerin A, Millichap JJ, Landsverk M, Grebe T, Lindstrom K, Strober J, Ait Mouhoub T, Zweier C, Steinraths M, Hebebrand M, Callewaert B, Abou Jamra R, Kautza-Lucht M, Wegler M, Kruszka P, Kumps C, Banne E, Waberski MB, Dieux A, Raible S, Krantz I, Medne L, Pechter K, Villard L, Guerrini R, Bianchini C, Barba C, Mei D, Blanc X, Kallay C, Ranza E, Yang XR, O'Heir E, Donald KA, Murugasen S, Bruwer Z, Calikoglu M, Mathews JM, Lesieur-Sebellin M, Baujat G, Derive N, Pierson TM, Murrell JR, Shillington A, Ormieres C, Rondeau S, Reis A, Fernandez-Jaen A, Au PYB, Sweetser DA, Briere LC, Couque N, Perrin L, Schymick J, Gueguen P, Lefebvre M, Van Andel M, Juusola J, Antonarakis SE, Parker JA, Burnett BG, Campeau PM.

Am J Hum Genet. 2024 Dec 24:S0002-9297(24)00418-X. doi: 10.1016/j.ajhg.2024.11.009. Online ahead of print.

Be a part of our future discoveries.Giving

Follow Pathology on FacebookInstagram